A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema

Novartis Investigative Site, Marseille

Novartis Investigative Site, Marseille

Novartis Investigative Site, Caen

Novartis Investigative Site, Puilboreau

Novartis Investigative Site, Saint-Brieuc

Novartis Investigative Site, Besançon

Novartis Investigative Site, Nîmes

Novartis Investigative Site, Toulouse

Novartis Investigative Site, St.-Jean

Novartis Investigative Site, Bordeaux

Novartis Investigative Site, Bordeaux

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Cesson-Sévigné

Novartis Investigative Site, Tours

Novartis Investigative Site, Grenoble

Novartis Investigative Site, Saint-Etienne

Novartis Investigative Site, Saint-Priest-en-Jarez

Novartis Investigative Site, Saitnt Herblain

Novartis Investigative Site, Angers

Novartis Investigative Site, Reims

Novartis Investigative Site, Vandœuvre-lès-Nancy

Novartis Investigative Site, Vannes

Novartis Investigative Site, Lille

Novartis Investigative Site, Clermont-Ferrand

Novartis Investigative Site, Strasbourg

Novartis Investigative Site, Lyon

Novartis Investigative Site, Lyon

Novartis Investigative Site, Lyon

Novartis Investigative Site, Lyon

Novartis Investigative Site, Paris

Novartis Investigative Site, Paris

Novartis Investigative Site, Paris

Novartis Investigative Site, Paris

Novartis Investigative Site, Rouen

Novartis Investigative Site, Melun

Novartis Investigative Site, Mantes La Joile

Novartis Investigative Site, Amiens

Novartis Investigative Site, Bobigny

Novartis Investigative Site, Créteil

Novartis Investigative Site, Osny

Novartis Investigative Site, Paris

Novartis Investigative Site, Nice